[Federal Register: August 11, 2008 (Volume 73, Number 155)]
[Notices]
[Page 46606-46607]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr11au08-41]
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Office of the Secretary
Defense Health Board Meeting
AGENCY: Department of Defense (DoD).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: Pursuant to the Federal Advisory Committee Act of 1972 (5
U.S.C., Appendix as amended), the Sunshine in the Government Act of
1976 (5 U.S.C. 552b, as amended), and 41 CFR 102-3.150, and in
accordance with section 10(a)(2) of Public Law, the following meeting
of the Defense Health Board (DHB) is announced:
DATES: September 4, 2008 (8 a.m.-4:15 p.m.) (Open Session). September
5, 2008 (8:30 a.m.-3:30 p.m.) (Open Session).
ADDRESSES: Sheraton Crystal City, 1800 Jefferson Davis Highway,
Arlington, VA 22202.
FOR FURTHER INFORMATION CONTACT: Colonel Roger L. Gibson, Executive
Secretary, Defense Health Board, Five Skyline Place, 5111 Leesburg
Pike, Suite 810, Falls Church, Virginia 22041-3206, (703) 681-8448,
EXT. 1228, Fax: (703) 681-3317, roger.gibson@ha.osd.mil.
SUPPLEMENTARY INFORMATION: Additional information, agenda updates, and
meeting registration are available online at the Defense Health Board
Web site, http://www.ha.osd.mil/dhb. The public is encouraged to
register for the meeting. If special accommodations are required to
attend (sign language, wheelchair accessibility) please contact Ms.
Lisa Jarrett at (703) 681-8448 ext. 1280 by August 21, 2008. Written
statements may be mailed to the above address, e-mailed to
dhb@ha.osd.mil or faxed to (703) 681-3317.
Purpose of the Meeting: The purpose of the meeting is to address
and deliberate pending and new Board issues and provide briefings for
Board members on topics related to ongoing Board business.
Agenda: On September 4, 2008 during the morning session, the Board
will receive updates on the activities from Defense Health Board
subcommittees: Trauma and Injury/Combat Casualty Care, Traumatic Brain
Injury External Advisory, and the Traumatic Brain Injury Family Care
Giver's Panel. The Board will discuss plans for identifying best
practices in health care delivery in response to the recommendations
outlined in the Board's Task Force for the Future of Military
Healthcare report. The Board will also receive presentations on the
basics of the TRICARE Health Plan and address issues of Environmental
Risk Assessments in Operational Settings. The Vaccine Safety and
Effectiveness Workgroup and the Biowarfare Countermeasures Subcommittee
will provide updates on their activities. The Board will conduct an
administrative session on the afternoon of September 4, 2008.
On September 5, 2008, the Board will discuss Amputee Care
Sustainment, the DoD's plan for a Joint Pathology Center, and the
activities of the Deployment Health Research Center. Questions will be
presented to the Board on Lyme Disease Therapy and Applied Behavior
Analysis (ABA) treatment for Autism. The meeting will conclude with
open discussion and an awards ceremony.
Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR 102-3.140 through
102-3.165 and subject availability of space, the Defense Health Board
meeting from 80 a.m. to 4:15 p.m. on September 4, 2008 and from 8:30
a.m. to 3:30 p.m. on September 5, 2008 is open to the public. Any
member of the public wishing to provide input to the Defense Health
Board should submit a written statement in accordance with 41 CFR 102-
3.140(C) and section 10(a)(3) of the Federal Advisory Committee Act,
and the procedures described in this notice. Written statement should
be not longer than two
[[Page 46607]]
type-written pages and must address the following detail: The issue,
discussion, and a recommended course of action. Supporting
documentation may also be included as needed to establish the
appropriate historical context and to provide any necessary background
information.
Individuals desiring to submit a written statement may do so
through the Board's Designated Federal Officer at the address detailed
above at any point. However, if the written statement is not received
at least 10 calendar days prior to the meeting, which is subject to
this notice, then it may not be provided to or considered by the
Defense Health Board until the next open meeting.
The Designated Federal Officer will review all timely submissions
with the Defense Health Board Chairperson, and ensure they are provided
to members of the Defense Health Board before the meeting that is
subject to this notice. After reviewing the written comments, the
Chairperson and the Designated Federal Officer may choose to invite the
submitter of the comments to orally present their issue during an open
portion of this meeting or at a future meeting.
The Designated Federal Officer, in consultation with the Defense
Health Board Chairperson, may, if desired, allot a specific amount of
time for members of the public to present their issues for review and
discussion by the Defense Health Board.
Dated: August 5, 2008.
Patricia L. Toppings,
OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. E8-18599 Filed 8-7-08; 4:15 pm]
BILLING CODE 5001-06-P